Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Antoine Boudot"'
Autor:
Kenneth Olivier, Ribhu Nayar, Sonal Jangalwe, Mollie Jurewicz, Antoine Boudot, Robert Prenovitz, Elizabeth Olesin, Daniel Pollacksmith, Qikai Xu, Yifan Wang, Amy Virbasius, Jeffery Li, Holly Whitton, Garrett Dunlap, Alexander Cristofaro, Nancy Nabilsi, Ruan Zhang, Candace Perullo, Sida Liao, Kenneth Jahan, Gavin MacBeath
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/d8b81dd10b4b49dd8f55a003956d8da4
Autor:
Antoine Boudot, Gwenneg Kerdivel, Denis Habauzit, Jerome Eeckhoute, François Le Dily, Gilles Flouriot, Michel Samson, Farzad Pakdel
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e20898 (2011)
CXCR4 and CXCR7 are the two receptors for the chemokine CXCL12, a key mediator of the growth effect of estrogens (E2) in estrogen receptor (ER)-positive breast cancers. In this study we examined E2-regulation of the CXCL12 axis components and their i
Externí odkaz:
https://doaj.org/article/38cf70efc7334720b3e2e3650007141c
Autor:
Cagan Gurer, Gavin MacBeath, Mollie Jurewicz, Nancy Nabilsi, Antoine Boudot, Jenny Tadros, Tary Traore, Maytal Bowman, Elizabeth Hall, Yifan Wang, Qikai Xu, Victor Ospina
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Mollie Jurewicz, Elizabeth Hall, Alexandra Luther, Kimberly Cirelli, Vivin Karthik, Kenneth Jahan, Tary Traore, Maytal Bowman, Victor Ospina, Sonal Jangalwe, Shubhangi Kamalia, Sadie Lee, Daniel Pollacksmith, Sida Liao, Amy Virbasius, Kristen Murray, Jillian Oliveira, Lisa Nip, Christina Lam, Livio Dukaj, Danielle Ramsdell, Jin He, Joel Sher, Ribhu Nayar, Qikai Xu, Yifan Wang, Antoine Boudot, Cagan Gurer, Gavin MacBeath
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Ashish Kalra, Jeffrey D. Kearns, Adnan O. Abu-Yousif, Gavin MacBeath, Alexey Lugovskoy, Maria Håkansson, Derek T. Logan, Birgit Schoeberl, Martin Welin, Melissa Geddie, Ulrik B. Nielsen, Neeraj Kohli, Tim Maiwald, Jessica B. Casaletto, Aaron Fulgham, Brian Harms, Shrikanta Chattopadhyay, Stephen Su, Maja Razlog, Antoine Boudot, Kristina Masson, Andreas Raue
Publikováno v:
Proceedings of the National Academy of Sciences. 116:7533-7542
Activation of the Met receptor tyrosine kinase, either by its ligand, hepatocyte growth factor (HGF), or via ligand-independent mechanisms, such as MET amplification or receptor overexpression, has been implicated in driving tumor proliferation, meta
Autor:
Ribhu Nayar, Sonal Jangalwe, Mollie Jurewicz, Antoine Boudot, Andrew Basinski, Robert Prenovitz, Elizabeth Olesin, Daniel Pollacksmith, Qikai Xu, Yifan Wang, Amy Virbasius, Jeffery Li, Holly Whitton, Garrett Dunlap, Alexander Cristofaro, Nancy Nabilsi, Ruan Zhang, Candace Perullo, Sida Liao, Kenneth Jahan, Kenneth Olivier, Gavin MacBeath
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Approximately 30–40% of AML patients relapse following allogeneic hematopoietic stem cell transplant therapy, leaving them with very few treatment options.1 2 Rare patients that naturally develop an HA-1-specific graft-versus-leukemia T
Autor:
Krista Daniel, Shrikanta Chattopadhyay, Kenneth N. Olivier, Alexandra Luther, Cisem Karaca, Gavin MacBeath, Yifan Wang, Livio Dukaj, Antoine Boudot, Amy Virbasius, Alexandra Cristofaro, Cagan Gurer, Andrew Basinski, Daniel Pollacksmith, Kenneth L Jahan, Qikai Xu, Danielle Ramsdell, Hannah L. Bader, Mollie M Jurewicz, Ribhu Nayar, Candace R. Perullo, Sida Liao, Kimberly M Cirelli, Lisa Nip, Sonal Jangalwe, Anna Labrozzi
Publikováno v:
Blood. 138:1704-1704
Background Approximately 50% of AML patients relapse following allogeneic hematopoietic stem cell transplant therapy, leaving them with very few treatment options (Rautenberg et al. (2019) Int. J. Mol. Sci. 20:228). Rare patients who naturally develo
Autor:
Hannah L. Bader, Gavin MacBeath, Antoine Boudot, Christopher Malcuit, Shrikanta Chattopadhyay, Ryo Takeuchi, James W. Murray, Warren Jaworowicz, Emmett Hedblom
Publikováno v:
Blood. 138:3863-3863
Background: While adoptive cell therapies such as CAR-T therapies have transformed the treatment of lymphoid malignancies by targeting lineage-specific antigens, they have yet to demonstrate safety and efficacy against myeloid malignancies. T cells e
Autor:
Jared L. Dietze, Daniel A. Rothenberg, Terri A. Addona, Antoine Boudot, Jessica Kohler, Jennifer G. Abelin, Vikram R. Juneja, Paul J. Turcott, Brandon P. Conn, Marit M. van Buuren, Scott P. Goulding, Christopher D. McGann, Richard B. Gaynor, John R. Srouji, Kendra C. Foley, Jae Won Choi, Michael S. Rooney, Divya Lenkala
Publikováno v:
Cell Reports Methods. 1:100084
Summary Oncogenic mutations in KRAS can be recognized by T cells on specific class I human leukocyte antigen (HLA-I) molecules, leading to tumor control. To date, the discovery of T cell targets from KRAS mutations has relied on occasional T cell res
Autor:
Vikram R. Juneja, Terri A. Addona, John Srouji, Jae Won Choi, Michael S. Rooney, Brandon P. Conn, Paul J. Turcott, Christopher D. McGann, Jennifer G. Abelin, Richard B. Gaynor, Antoine Boudot, Marit M. van Buuren, Scott P. Goulding, Jessica Kohler, Divya Lenkala, Daniel A. Rothenberg, Jared L. Dietze
Publikováno v:
Cancer Research. 80:PO-015
Response rates to immunotherapies in pancreatic ductal adenocarcinoma (PDAC) patients are low. However, cases with long-term survival have been correlated with both T cell infiltration and quality of neoantigens (i.e., epitopes from mutations present